Today: 17 April 2026
Rightmove share price today: RMV stock dips as investors eye Feb. 27 results
12 January 2026
1 min read

Rightmove share price today: RMV stock dips as investors eye Feb. 27 results

London, January 12, 2026, 08:46 GMT — Normal trading hours.

Rightmove shares slipped slightly in early London trade Monday, last down 0.12% at 515.0 pence, after kicking off at 516.8 pence. Over the past year, the stock’s range has stretched from 474.5 to 827.0 pence.

Rightmove’s next big milestone is fast approaching. The company will release its 2025 full-year results on Feb. 27. Its annual general meeting is scheduled for May, followed by the final dividend payment later that month.

This is significant since the company has been urging investors to accept increased spending ahead of any returns. When the numbers come out in late February, they’ll reveal if the portal continues to convert pricing power into cash as it rolls out new tools.

Rightmove stuck to its 2025 forecast in its latest trading and investor update, projecting around 9% revenue growth and a 70% underlying operating margin. Membership growth is expected to hit about 1%, with ARPA climbing between £95 and £105. Looking ahead to 2026, the company anticipates revenue growth of 8% to 10% and underlying operating profit rising 3% to 5%. The update also revealed plans for roughly £12 million in incremental P&L investment, along with an additional £6 million to be capitalised. CEO Johan Svanstrom commented, “AI is now becoming absolutely central to how we run our business and plan for the future.” Rightmove Plc

ARPA — average revenue per advertiser — matters to investors because it shows how much Rightmove can charge agents and homebuilders for listings and upgrades. When this number falls short, profit forecasts usually take a hit fast.

Even market leaders face competition lurking nearby. Agents have choices, and the stock often reacts to signs of churn, discounts, or changes in the mix of premium packages.

Rightmove faces a separate legal threat: estate agents are reportedly preparing a claim worth up to 1 billion pounds, accusing the firm of charging “excessive and unfair fees” for listings. The lawsuit is being driven by Jeremy Newman, who once served on the UK antitrust watchdog’s panel. Rightmove, however, maintains confidence in the value it offers its partners. Reuters

Monday’s shift was minor, yet the trade has been volatile since last fall as investors wrestled with the cost of the upcoming phase. Should the company ramp up spending quicker than it raises fees, the short-term numbers could look grim.

Stock Market Today

  • Axon Enterprise Shares Show Volatility but Fairly Valued on DCF Model
    April 16, 2026, 11:07 PM EDT. Axon Enterprise's stock has swung sharply, with a 29.7% drop over 12 months but a 75.1% gain over three years. The shares trade around $393, near the estimated intrinsic value of $381 from a Discounted Cash Flow (DCF) analysis, which values future free cash flow. This suggests the stock is roughly fairly valued, with a small 3.2% overvaluation margin that is typical for such models. Axon scores low on valuation metrics, reflecting investor caution amid its ongoing growth investments. Market participants should watch these dynamics closely, as DCF intrinsic value and sales-based price multiples offer different perspectives on the company's worth amid share price fluctuations.

Latest article

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Babcock (BAB.L) share price edges toward 52-week high as traders line up for Jan 26 update
Previous Story

Babcock (BAB.L) share price edges toward 52-week high as traders line up for Jan 26 update

National Grid plc stock drops today as markets wobble; dividend clock ticks on NG.L
Next Story

National Grid plc stock drops today as markets wobble; dividend clock ticks on NG.L

Go toTop